antiviral and anticancer chemotherapeutic agents that makes use of a disease-specific nucleic acid sequence to template the association of a prodrug with a catalyst which catalyzes the release of the drug. Herein, we report on the effect of mismatches, sterics, and electronics on the rate and specificity of drug and probe release in both two and three component model systems, and on the stability of the
最近,我们描述了一种设计高度选择性的抗病毒和抗癌
化学治疗剂的新概念,该概念利用疾病特异性核酸序列来模板化前药与催化药物释放的催化剂的缔合。本文中,我们报道了错配,空间位阻和电子学对药物和探针释放速率和特异性的影响,包括两个和三个组件模型系统,以及前药接头在人血清中的稳定性。